Edition:
United Kingdom

GlaxoSmithKline Consumer Healthcare Ltd (GLSM.NS)

GLSM.NS on National Stock Exchange of India

7,280.05INR
7:56am BST
Change (% chg)

Rs23.45 (+0.32%)
Prev Close
Rs7,256.60
Open
Rs7,295.00
Day's High
Rs7,329.95
Day's Low
Rs7,180.30
Volume
6,127
Avg. Vol
17,670
52-wk High
Rs7,948.00
52-wk Low
Rs6,310.00

Latest Key Developments (Source: Significant Developments)

India's Glaxosmithkline Consumer Healthcare March-Qtr Profit Rises
Friday, 10 May 2019 

May 10 (Reuters) - GlaxoSmithKline Consumer Healthcare Ltd ::MARCH QUARTER PROFIT 2.86 BILLION RUPEES VERSUS PROFIT OF 2.12 BILLION RUPEES LAST YEAR.MARCH QUARTER REVENUE FROM OPERATIONS 12.86 BILLION RUPEES VERSUS 11.80 BILLION RUPEES LAST YEAR.RECOMMENDED DIVIDEND OF 105 RUPEES PER SHARE.  Full Article

Glaxosmithkline Conducting Strategic Review Of Co's Nutrition Brands In India - Spokesperson
Wednesday, 28 Nov 2018 

Nov 28 (Reuters) - GlaxoSmithKline Consumer Healthcare Ltd ::GLAXOSMITHKLINE CONDUCTING STRATEGIC REVIEW OF CO'S NUTRITION BRANDS IN INDIA AND EXPECTS TO CONCLUDE THAT BY END 2018 - SPOKESPERSON.  Full Article

India's Glaxosmithkline Consumer Healthcare Sept-Qtr Profit Rises
Thursday, 1 Nov 2018 

Nov 1 (Reuters) - GlaxoSmithKline Consumer Healthcare Ltd ::SEPT QUARTER PROFIT 2.75 BILLION RUPEES VERSUS PROFIT OF 1.92 BILLION RUPEES LAST YEAR.SEPT QUARTER REVENUE FROM OPERATIONS 12.72 BILLION RUPEES VERSUS 11.12 BILLION RUPEES LAST YEAR.  Full Article

Glaxosmithkline Consumer Healthcare Gets Shareholders' Nod For Appointment Of Navneet Saluja As MD
Friday, 10 Aug 2018 

Aug 10 (Reuters) - GlaxoSmithKline Consumer Healthcare Ltd ::GETS SHAREHOLDERS' NOD FOR APPOINTMENT OF NAVNEET SALUJA AS MD.  Full Article

Glaxosmithkline Consumer Healthcare Gets Shareholders' Nod To Appoint Navneet Saluja As MD
Thursday, 9 Aug 2018 

Aug 9 (Reuters) - GlaxoSmithKline Consumer Healthcare Ltd ::GETS SHAREHOLDERS' NOD TO APPOINT NAVNEET SALUJA AS MANAGING DIRECTOR.  Full Article

India's Glaxosmithkline Consumer Healthcare June-Qtr Profit Rises
Tuesday, 7 Aug 2018 

Aug 7 (Reuters) - GlaxoSmithKline Consumer Healthcare Ltd ::JUNE QUARTER PROFIT 2 BILLION RUPEES VERSUS PROFIT OF 1.32 BILLION RUPEES LAST YEAR.CONSENSUS FORECAST FOR JUNE QUARTER PROFIT WAS 1.68 BILLION RUPEES.JUNE QUARTER REVENUE FROM OPERATIONS 11.07 BILLION RUPEES VERSUS 10.46 BILLION RUPEES LAST YEAR.  Full Article

India's GlaxoSmithKline Consumer Healthcare Dec Qtr Profit Up 20 Pct
Monday, 12 Feb 2018 

Feb 12 (Reuters) - GlaxoSmithKline Consumer Healthcare Ltd ::DEC QUARTER PROFIT 1.64 BILLION RUPEES VERSUS PROFIT OF 1.36 BILLION RUPEES LAST YEAR.DEC QUARTER REVENUE FROM OPERATIONS 10.35 BILLION RUPEES VERSUS 9.60 BILLION RUPEES LAST YEAR.  Full Article

Neurometrix, Glaxosmithkline Announce Collaboration To Develop Quell Wearable Pain Relief Technology
Wednesday, 17 Jan 2018 

Jan 17 (Reuters) - Glaxosmithkline Consumer Healthcare Ltd ::NEUROMETRIX AND GLAXOSMITHKLINE CONSUMER HEALTHCARE ANNOUNCE STRATEGIC COLLABORATION TO DEVELOP AND EXPAND ACCESS TO QUELL WEARABLE PAIN RELIEF TECHNOLOGY.NEUROMETRIX INC - GSK CONSUMER HEALTHCARE ACQUIRES EXCLUSIVE OWNERSHIP OF QUELL TECHNOLOGY FOR MARKETS OUTSIDE U.S..NEUROMETRIX INC - NEUROMETRIX RETAINS EXCLUSIVE OWNERSHIP OF QUELL TECHNOLOGY IN U.S. MARKET..NEUROMETRIX - CO, GSK CONSUMER HEALTHCARE TO CO-FUND DEVELOPMENT OF QUELL TECHNOLOGY FOR 3 YEARS BEGINNING IN 2018 THROUGH 2020.NEUROMETRIX - GSK CONSUMER HEALTHCARE TO PAY CO $5 MILLION FOR ASSETS RELATING TO QUELL TECHNOLOGY FOR MARKETS OUTSIDE U.S.NEUROMETRIX - GSK CONSUMER HEALTHCARE TO PAY CO UP TO $21.5M FOR QUELL UPON ACHIEVEMENT OF CERTAIN MILESTONES.  Full Article

India's Glaxosmithkline Consumer Healthcare Sept qtr profit up about 4 pct
Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - Glaxosmithkline Consumer Healthcare Ltd :Sept quarter net profit 1.92 billion rupees versus profit of 1.84 billion rupees last year.Sept quarter revenue from operations 11.15 billion rupees versus 11.93 billion rupees last year.  Full Article